121 unknown, 60 completed, 53 recruiting, 25 not yet recruiting. 74 Not applicable, 47 Phase 2, 24 Phase 3, 19 Phase 1, 18 Phase 4.
Follow Zhujiang Hospital: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma Infusion of Axicabtagene Ciloleucel - Relapsed/Refractory Diffuse Large B-cell Lymphoma | Phase 1 / Phase 2 | Recruiting | Zhujiang Hospital | 15 | 2027-02-01 | 2025-03-30 |
| Non-Interventional Study of Ranicabtagene Autoleucel Injection for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma Ranicabtagene Autoleucel Injection - B-Cell Non-Hodgkin Lymphoma (NHL) | Not yet recruiting | Hrain Biotechnology Co., Ltd. | 200 | 2026-10-30 | 2026-10-22 | |
| Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients Chronotherapy-based individualized low-morning high-evening tacrolimus dosing, conventional dosing regimen - End-Stage Renal Disease | Phase 4 | Not yet recruiting | The First Affiliated Hospital of Guangzhou Medical University | 100 | 2026-10-25 | 2026-10-16 |
| Evaluation of the Effects of Pulsed Electromagnetic Field on Inflammatory Knee Osteoarthritis Pulsed Electromagnetic Field (PEMF) Therapy, Sham Pulsed Electromagnetic Field (PEMF) Treatments - Knee Osteoarthritis (Knee OA) | Not applicable | Not yet recruiting | The Hong Kong Polytechnic University | 50 | 2026-09-15 | 2026-09-22 |
| Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia PID23 Injection - Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Lymphoblastic Leukemia | Early Phase 1 | Not yet recruiting | Zhujiang Hospital | 18 | 2026-08-01 | 2026-07-10 |
| Plasma Neprilysin for Predicting Sepsis Within 48 Hours in ICU Patients With Infection or Suspected Infection Plasma Neprilysin Measurement, Conventional Sepsis Biomarker Measurement, Sublingual Microcirculation Assessment - Sepsis, Infection | Not yet recruiting | Zhujiang Hospital | 488 | 2026-08-01 | 2026-09-01 | |
| The Therapeutic Potential of Mesenchymal Stem Cell-derived Exosomes in Peritoneal Dysfunction MSC-Exos - Peritoneal Dysfunction | Phase 1 | Not yet recruiting | Zhujiang Hospital | 12 | 2026-08-01 | 2026-08-28 |
| Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma Neoadjuvant Chemo-Immunotherapy - Locally Advanced Sinonasal Carcinoma | Phase 2 | Not yet recruiting | Sun Yat-sen University | 23 | 2026-07-31 | 2026-06-25 |
| Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP Anrikefon, Nalfurafine - Pruritus Chronic, Kidney Diseases, Chronic | Phase 4 | Recruiting | Zhujiang Hospital | 50 | 2026-06-22 | 2026-08-25 |
| Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment Intrasaccular Flow Disruption Device - Intracranial Aneurysm | Recruiting | Xuanwu Hospital, Beijing | 1000 | 2026-06-10 | 2026-06-11 | |
| A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy humanized CD19 CAR-T Cells with TLR2 - B Lymphoblastic Leukemia/Lymphoma | Early Phase 1 | Not yet recruiting | Zhujiang Hospital | 60 | 2026-06-01 | 2026-01-12 |
| Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes LFD, PED Shield - Intracranial Aneurysms, Flow Diverter | Not applicable | Recruiting | Henan Provincial People's Hospital | 196 | 2026-05-21 | 2026-07-01 |
| Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China endovascular - Intracranial Dural Arteriovenous Fistula | Recruiting | Xuanwu Hospital, Beijing | 10050 | 2026-05-18 | 2026-06-04 | |
| A Study About Remote and Local Liver Surgery Remote Liver Surgery, Local Liver Surgery - Liver Diseases | Not applicable | Not yet recruiting | Tongji Hospital | 148 | 2026-05-16 | 2026-05-18 |
| Racecadotril for Organ Injury in Sepsis Patients Racecadotril, Water (Placebo) - Sepsis | Phase 1 / Phase 2 | Enrolling by invitation | Zhujiang Hospital | 44 | 2026-05-06 | 2026-05-28 |
| AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults Overweight and Obesity, Diabetes Mellitus, Type 2 | Not yet recruiting | Zhujiang Hospital | 2800 | 2026-05-01 | 2026-05-13 | |
| Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) Nafamostat Low-Dose Group, Nafamostat High-Dose Group - Continuous Renal Replacement Therapy (CRRT) | Phase 2 | Recruiting | Zhujiang Hospital | 92 | 2026-04-07 | 2026-04-14 |
| An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines With Metabolic Dysfunction-associated Fatty Liver Disease observational study, no intervention - Metabolic Dysfunction-associated Fatty Liver Disease | Not yet recruiting | Zhujiang Hospital | 200 | 2026-04-01 | 2026-03-06 | |
| Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma Observation, Postoperative Radiotherapy, PD-1 Inhibitor Maintenance Therapy - Locally Advanced Oral Squamous Cell Carcinoma, Locally Advanced Oropharyngeal Squamous Cell Carcinoma | Not yet recruiting | Zhujiang Hospital | 85 | 2026-04-01 | 2026-03-09 | |
| Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver Cirrhosis. observational study, no intervention - Cirrhosis | Not yet recruiting | Zhujiang Hospital | 200 | 2026-04-01 | 2026-03-06 |
Showing 20 of 272. Sign in to see all of them.
Pulmonary Disease, Chronic Obstructive (17) · Carcinoma, Hepatocellular (14) · Leukemia, Myeloid, Acute (12) · Sepsis (12) · Ischemic Stroke (11) · Recurrence (9) · Diabetes Mellitus, Type 2 (7) · Multiple Myeloma (7) · Urinary Bladder Neoplasms (6) · Intracranial Aneurysm (5) · Lymphoma (5) · Renal Insufficiency, Chronic (5) · Shock, Septic (5) · Asthma (4) · Infections (4)
Busulfan (9) · Cyclophosphamide (9) · Decitabine (5) · Observation (5) · Budesonide (4) · Budesonide, Formoterol Fumarate Drug Combination (4) · Cisplatin (4) · Fluorouracil (4) · Indocyanine Green (4) · Ascorbic Acid (3) · Control Groups (3) · Doxorubicin (3) · Endoscopy, Digestive System (3) · Etoposide (3) · Formoterol Fumarate (3)
China (249) · Indonesia (1) · Japan (1) · Thailand (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Qifa Liu (15) · Xin Chen, Doctor (8) · Hongwei Zhou, Professor (7) · Zhanguo Liu, M.D.PhD (6) · Mingxin Pan, Prof. (5) · Abai Xu, doctor (3) · Chihua Fang, MD (3) · Hong Chen, MD (3) · Huapeng Yu (3) · Mingxin Pan (3) · Changhai Ding, MD (2) · Chen Xin, Doctor (2) · Chuanzhi Duan, MD (2) · Chuanzhi Duan, Ph.D. (2)
PMID 11985941, PMID 12208186, PMID 12781847, PMID 17615366, PMID 18666139, PMID 20594393, PMID 20828377, PMID 21436087, PMID 21512182, PMID 22752522, PMID 22859284, PMID 23290142, PMID 23321438, PMID 23342209, PMID 23418004, PMID 23538237, PMID 23756745, PMID 23796341, PMID 23890935, PMID 24373477, PMID 24593273, PMID 25121791, PMID 25149296, PMID 25331477, PMID 25384923, PMID 26316566, PMID 26452114, PMID 26497954, PMID 26553302, PMID 26661467, PMID 26742998, PMID 27226859, PMID 27449221, PMID 27714681, PMID 27979794, PMID 27981751, PMID 29111907, PMID 29145879, PMID 29170270, PMID 29431126, PMID 29514693, PMID 29794089, PMID 30458805, PMID 30523146, PMID 30626424, PMID 30628875, PMID 30885871, PMID 30896447, PMID 30950504, PMID 31290336